Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial-Reference-Cited by-同舟云学术

Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial

Published:2023-07 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kuter David J.^ORCID,Bonkovsky Herbert L.^ORCID,Monroy Susana,Ross Gayle^ORCID,Guillén-Navarro Encarna,Cappellini Maria Domenica^ORCID,Minder Anna-Elisabeth^ORCID,Hother-Nielsen Ole^ORCID,Ventura Paolo^ORCID,Jia Gang,Sweetser Marianne T.,Thapar Manish

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. Porphyrias;Puy;Lancet,2010

2. Acute hepatic porphyrias: review and recent progress;Wang;Hepatol Commun,2019

3. Biochemical diagnosis of acute hepatic porphyria: updated expert recommendations for primary care physicians;Anderson;Am J Med Sci,2021

4. Acute hepatic porphyrias: recommendations for evaluation and long-term management;Balwani;Hepatology,2017

5. Porphyria;Bissell;N Engl J Med,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized dosage of Givosiran in acute intermittent porphyria;Medicina Clínica;2024-09

2. Personalized dosage of Givosiran in acute intermittent porphyria;Medicina Clínica (English Edition);2024-09

3. Effectiveness and tolerability of givosiran for the management of acute hepatic porphyria: A monocenter real-life evaluation;Molecular Genetics and Metabolism Reports;2024-09

4. Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders;Blood;2024-08-22

5. RNA interference therapy in cardiology: will new targets improve therapeutic goals?;Drugs in Context;2024-08-20